Literature DB >> 22098612

Iron metabolism and the role of HFE gene polymorphisms in Wilson disease.

Jan Pfeiffenberger1, Daniel N Gotthardt, Thomas Herrmann, Jessica Seessle, Uta Merle, Peter Schirmacher, Wolfgang Stremmel, Karl Heinz Weiss.   

Abstract

UNLABELLED: Wilson disease (WD) is a rare inherited disorder of copper metabolism, which can lead to severe liver failure and to a variety of neuropsychiatric symptoms. Previous animal studies and case reports suggest that hepatic iron overload and alterations in iron processing are associated with WD. The aim of this study was the assessment of iron metabolism and of the frequency of the most common HFE gene polymorphisms in WD patients. PATIENTS AND METHODS: Data from 143 patients with WD were analysed. Clinical presentation, liver function and iron metabolism parameters were recorded. Blood samples of the patients were analysed for HFE gene alterations (H63D; C282Y). Twenty-seven liver biopsies of these patients were studied with regard to iron content and fibrosis score.
RESULTS: Contrary to previous reports of HFE gene polymorphisms in WD patients, in our cohort the allele frequencies (C282Y: 2.1%; H63D: 7.3%) were in line with frequencies obtained for general population. Male WD patients with decreased serum ceruloplasmin (Cp), showed increased serum ferritin levels. Hepatic iron content was normal in most cases. DISCUSSION: Male patients with very low Cp serum concentrations showed slightly elevated median serum ferritin concentrations, probably related to lack of ferroxidase acitivity. However, in consideration of absolute numbers of ferritin concentrations, these changes seem to be of minor clinical relevance.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22098612     DOI: 10.1111/j.1478-3231.2011.02661.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  9 in total

Review 1.  Genetics and epigenetic factors of Wilson disease.

Authors:  Valentina Medici; Janine M LaSalle
Journal:  Ann Transl Med       Date:  2019-04

2.  Wilson disease: At the crossroads between genetics and epigenetics-A review of the evidence.

Authors:  Dorothy A Kieffer; Valentina Medici
Journal:  Liver Res       Date:  2017-08-16

3.  Lenticular nucleus hyperechogenicity in Wilson's disease reflects local copper, but not iron accumulation.

Authors:  Uwe Walter; Marta Skowrońska; Tomasz Litwin; Grażyna Maria Szpak; Katarzyna Jabłonka-Salach; David Skoloudík; Ewa Bulska; Anna Członkowska
Journal:  J Neural Transm (Vienna)       Date:  2014-03-11       Impact factor: 3.575

4.  Osteoporosis and bone mineral density in patients with Wilson's disease: a systematic review and meta-analysis.

Authors:  J Chenbhanich; C Thongprayoon; A Atsawarungruangkit; T Phupitakphol; W Cheungpasitporn
Journal:  Osteoporos Int       Date:  2017-11-06       Impact factor: 4.507

Review 5.  Wilson's disease and other neurological copper disorders.

Authors:  Oliver Bandmann; Karl Heinz Weiss; Stephen G Kaler
Journal:  Lancet Neurol       Date:  2015-01       Impact factor: 44.182

6.  Identification of potential modifier genes in Chinese patients with Wilson disease.

Authors:  Donghu Zhou; Siyu Jia; Liping Yi; Zhen Wu; Yi Song; Bei Zhang; Yanmeng Li; Xiaoxi Yang; Anjian Xu; Xiaojin Li; Wei Zhang; Weijia Duan; Zhenkun Li; Saiping Qi; Zhibin Chen; Qin Ouyang; Jidong Jia; Jian Huang; Xiaojuan Ou; Hong You
Journal:  Metallomics       Date:  2022-05-27       Impact factor: 4.636

7.  Iron metabolism is disturbed and anti-copper treatment improves but does not normalize iron metabolism in Wilson's disease.

Authors:  Grażyna Gromadzka; Diana Wierzbicka; Tomasz Litwin; Adam Przybyłkowski
Journal:  Biometals       Date:  2021-02-08       Impact factor: 2.949

8.  Characterization of timed changes in hepatic copper concentrations, methionine metabolism, gene expression, and global DNA methylation in the Jackson toxic milk mouse model of Wilson disease.

Authors:  Anh Le; Noreene M Shibata; Samuel W French; Kyoungmi Kim; Kusum K Kharbanda; Mohammad S Islam; Janine M LaSalle; Charles H Halsted; Carl L Keen; Valentina Medici
Journal:  Int J Mol Sci       Date:  2014-05-07       Impact factor: 5.923

9.  Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls.

Authors:  Qing Ye; Bao-Xin Qian; Wei-Li Yin; Feng-Mei Wang; Tao Han
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.